Growth Opportunities in the U.S. Point Of Care Lipid Test Industry

Polaris Market Research has published a brand-new report titled U.S. Point of Care Lipid Test Market Size, Share, Trends, Industry Analysis Report By Product (Instruments, Consumables), By Application, By Disease Indication, By End Use– Market Forecast, 2025–2034 that includes extensive information and analysis of the industry dynamics. The opportunities and challenges in the report's dynamical trends might be useful for the worldwide U.S. Point Of Care Lipid Test Market. The study provides an outline of the market's foundation and organizational structure and forecasts an increase in market share. The study offers a comprehensive analysis of the U.S. Point Of Care Lipid Test market size, present revenue, regular deliverables, share, and profit projections. The study report includes a sizable database on future market forecasting based on an examination of previous data.

Brief About the Report

The market's supply-side and demand-side U.S. Point Of Care Lipid Test market trends are evaluated in the study. The study provides important details on applications and statistics, which are compiled in the report to provide a market prediction. Additionally, it offers thorough explanations of SWOT and PESTLE analyses depending on changes in the region and industry. It sheds light on risks, obstacles, and uncertainties, as well as present and future possibilities and challenges in the market.

U.S. Point Of Care Lipid Test Market size and share is currently valued at USD 312.04 million in 2024 and is anticipated to generate an estimated USD 553.25 Million by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 5.9% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034

The U.S. Point of Care (POC) Lipid Test Market refers to diagnostic testing solutions designed to measure cholesterol, HDL, LDL, triglycerides, and other lipid biomarkers at or near the site of patient care without the need for centralized laboratories. These systems help clinicians and patients make faster decisions for cardiovascular disease risk management. Market growth is driven by rising incidences of obesity, diabetes, hypertension, and lifestyle disorders, which increase demand for regular lipid monitoring. Technological advancements such as portable analyzers, smartphone-linked devices, and automated biosensors are supporting adoption in clinics, pharmacies, and home settings. Industry trends highlight increasing preference for decentralized testing and preventive healthcare. Government initiatives supporting cardiovascular risk screening and reimbursement improvements also contribute to demand. The market outlook suggests strong expansion as healthcare providers shift toward personalized medicine. Additionally, telehealth integration enables remote monitoring and immediate test feedback, expanding scope. In the forecast period, growth opportunities will emerge from AI-based diagnostics, cloud-connected analyzers, and consumer wellness devices offering lipid metabolism insights. Increasing adoption across corporate health programs and elderly care settings further extends the market scope. Overall, the U.S. POC lipid test industry is positioned for steady growth due to rising awareness and preventive care needs.

Key Aspects Covered in The Report

  • Market size and growth rate during the forecast period.
  • Key vendors operating in the market with their company profiles
  • Opportunities and threats faced by the existing vendors in the market.
  • Trending factors influencing the market in the geographical regions.
  • In-depth understanding of market drivers, constraints, and major micro markets.
  • The critical data of each segment is highlighted at an extensive level.

U.S. Point Of Care Lipid Test Market Segmentation Analysis

The study offers a thorough analysis of the numerous market segments, including application type, product component, service types, and several geographic locations. The report's segment analysis section contains thoroughly researched expert-verified industry data. Strategic recommendations are given in terms of key business segments based on market estimations.

𝐄𝐱𝐩π₯𝐨𝐫𝐞 π“π‘πž 𝐂𝐨𝐦𝐩π₯𝐞𝐭𝐞 π‚π¨π¦π©π«πžπ‘πžπ§π¬π’π―πž π‘πžπ©π¨π«π­ π‡πžπ«πž:

https://www.polarismarketresearch.com/industry-analysis/us-point-of-care-lipid-test-market

Leading Players Analysis

The research report's chapter is entirely devoted to the competition environment. The U.S. Point Of Care Lipid Test market key players are examined, analyzing information on their evaluation and development in addition to a quick review of the company. Understanding the techniques employed by businesses and the steps they have recently taken to combat intense rivalry allows one to examine the competitive landscape. It covers each player's company profiles comprising sales, revenue, share, recent developments, SWOT analysis, capacity, production, revenue, gross margin, growth rate, and strategies employed by the major market players.

Different potentials in the domestic and regional markets are revealed by regional analysis of the sector. Each regional industry associated with this market is carefully examined to determine its potential for growth in the present and the future. Moreover, information on recent mergers and acquisitions that have taken place in the market is the subject of the research. This section provides important financial information about mergers and acquisitions that have recently shaped the U.S. Point Of Care Lipid Test industry.

Top Players:

  • Abbott Laboratories
  • Callegari Srl
  • F. Hoffmann-La Roche Ltd.
  • Menarini Group
  • MiCoBio
  • Nova Biomedical
  • SD Biosensor, Inc.
  • Sinocare Inc.
  • VivaChek Biotech (Hangzhou) Co., Ltd.

Regions Covered in This Report Are

  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and the Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and the rest of South America)
  • The Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, South Africa, and the Rest of the Middle East and Africa)

Report Summary

The analysis focuses on the regional forecast by type and application and the U.S. Point Of Care Lipid Test market sales and revenue prediction. The research report features data about the target market, such as pricing trends, customer requirements, and competitor analysis. The market growth has been examined using analytical approaches like PESTLE analysis, Porter's Five Forces analysis, feasibility studies, player-specific SWOT analyses, and ROI analyses.

Objectives of the Report

Read More